Key result
Stimulation of α1- or β1-adrenergic receptors reduced IKr amplitude, but pretreatment with one agonist markedly blunted the reduction induced by the other, demonstrating functional cross-talk.
Functional cross-talk between α1- and β1-adrenergic receptors non-linearly regulates IKr in ventricular myocytes, potentially forming a protective mechanism against excessive adrenergic stimulation.
Cross-talk between α1- and β1-ARs may blunt excessive IKr suppression; leaves open clinical relevance for arrhythmia risk.
The rapidly activating delayed rectifier potassium current (IKr) plays a critical role in cardiac repolarization. Although IKr is known to be regulated by both α1- and β1-adrenergic receptors (ARs), the cross-talk and feedback mechanisms that dictate its response to α1- and β1-AR activation are not known. In the present study, IKr was recorded using the whole-cell patch-clamp technique. IKr amplitude was measured before and after the sequential application of selective adrenergic agonists targeting α1- and β1-ARs. Stimulation of either receptor alone (α1-ARs using 1 μM phenylephrine (PE) or β1-ARs using 10 μM xamoterol (Xamo)) reduced IKr by 0.22 ± 0.03 and 0.28 ± 0.01, respectively. The voltage-dependent activation curve of IKr shifted in the negative direction. The half-maximal activation voltage (V0.5) was altered by -6.35 ± 1.53 and -1.95 ± 2.22 mV, respectively, with no major change in the slope factor (k). When myocytes were pretreated with Xamo, PE-induced reduction in IKr was markedly blunted and the corresponding change in V0.5 was significantly altered. Similarly, when cells were pretreated with PE, Xamo-induced reduction of IKr was significantly attenuated. The present results demonstrate that functional cross-talk between α1- and β1-AR signaling regulates IKr. Such non-linear regulation may form a protective mechanism under excessive adrenergic stimulation.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2014) studied this question. Sequential application of selective adrenergic agonists targeting α1- and β1-ARs (phenylephrine and xamoterol) vs. Baseline / single receptor stimulation was evaluated on IKr amplitude and voltage-dependent activation curve (V0.5). Stimulation of α1- or β1-adrenergic receptors reduced IKr amplitude, but pretreatment with one agonist markedly blunted the reduction induced by the other, demonstrating functional cross-talk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: